Connable Office Inc Amgen Inc Transaction History

Connable Office Inc

$981 Million
Q3 2024

A detailed history of Connable Office Inc transactions in Amgen Inc stock. As of the latest transaction made, Connable Office Inc holds 6,972 shares of AMGN stock, worth $2.02 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares

6,972

Previous 6,935 0.53%

Holding current value

$2.02 Million

Previous $2.17 Million 3.69%

% of portfolio

0.23%

Previous 0.24%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 06, 2024	BUY	$309.38 - $337.38 $11,447 - $12,483	37 Added 0.53%	6,972 $2.25 Million
Q2 2024 Aug 06, 2024	SELL	$262.75 - $319.31 $441,157 - $536,121	-1,679 Reduced 19.49%	6,935 $2.17 Million
Q1 2024 Apr 30, 2024	SELL	$268.87 - $324.56 $489,612 - $591,023	-1,821 Reduced 17.45%	8,614 $2.45 Million
Q4 2023 Feb 12, 2024	SELL	$255.7 - $288.46 $12,529 - $14,134	-49 Reduced 0.47%	10,435 $3.01 Million
Q3 2023 Nov 08, 2023	SELL	$218.65 - $271.46 $484,747 - $601,826	-2,217 Reduced 17.46%	10,484 $2.82 Million
Q2 2023 Aug 07, 2023	SELL	$214.27 - $253.37 $50,781 - $60,048	-237 Reduced 1.83%	12,701 $2.82 Million
Q1 2023 Apr 17, 2023	SELL	$225.79 - $275.2 $27,997 - $34,124	-124 Reduced 0.95%	12,938 $3.13 Million
Q3 2022 Oct 26, 2022	SELL	$224.46 - $253.15 $13,243 - $14,935	-59 Reduced 0.45%	13,062 $2.94 Million
Q2 2022 Aug 01, 2022	BUY	$230.71 - $256.74 $467,418 - $520,155	2,026 Added 18.26%	13,121 $3.19 Million
Q1 2022 May 12, 2022	SELL	$219.27 - $242.57 $2,192 - $2,425	-10 Reduced 0.09%	11,095 $2.68 Million
Q4 2021 Feb 14, 2022	SELL	$198.88 - $227.6 $43,355 - $49,616	-218 Reduced 1.93%	11,105 $2.5 Million
Q3 2021 Nov 09, 2021	SELL	$212.27 - $248.7 $193,590 - $226,814	-912 Reduced 7.45%	11,323 $2.41 Million
Q2 2021 Aug 06, 2021	SELL	$233.58 - $259.14 $3,970 - $4,405	-17 Reduced 0.14%	12,235 $2.98 Million
Q1 2021 May 07, 2021	SELL	$221.91 - $258.6 $68,126 - $79,390	-307 Reduced 2.44%	12,252 $3.05 Million
Q3 2020 Nov 10, 2020	BUY	$234.65 - $260.95 $92,217 - $102,553	393 Added 3.23%	12,559 $3.19 Million
Q2 2020 Aug 10, 2020	SELL	$197.81 - $242.74 $522,811 - $641,561	-2,643 Reduced 17.85%	12,166 $2.87 Million
Q1 2020 May 08, 2020	SELL	$182.24 - $241.7 $1,822 - $2,417	-10 Reduced 0.07%	14,809 $3 Million
Q4 2019 Feb 07, 2020	SELL	$189.21 - $243.2 $16,650 - $21,401	-88 Reduced 0.59%	14,819 $3.57 Million
Q3 2019 Nov 12, 2019	SELL	$174.11 - $208.62 $10,272 - $12,308	-59 Reduced 0.39%	14,907 $2.89 Million
Q2 2019 Aug 06, 2019	SELL	$166.7 - $195.41 $9,001 - $10,552	-54 Reduced 0.36%	14,966 $2.76 Million
Q1 2019 May 07, 2019	BUY	$180.87 - $203.88 $7,596 - $8,562	42 Added 0.28%	15,020 $2.85 Million
Q4 2018 Feb 12, 2019	SELL	$178.4 - $208.25 $79,566 - $92,879	-446 Reduced 2.89%	14,978 $2.92 Million
Q3 2018 Nov 06, 2018	BUY	$185.29 - $208.89 $183,992 - $207,427	993 Added 6.88%	15,424 $3.2 Million
Q2 2018 Aug 07, 2018	BUY	$166.05 - $186.51 $1,826 - $2,051	11 Added 0.08%	14,431 $2.66 Million
Q1 2018 May 08, 2018	BUY	$169.43 - $198.0 $148,759 - $173,844	878 Added 6.48%	14,420 $2.46 Million
Q4 2017 Feb 07, 2018	SELL	$168.79 - $188.59 $123,554 - $138,047	-732 Reduced 5.13%	13,542 $2.36 Million
Q3 2017 Nov 03, 2017	BUY	$167.29 - $191.0 $2.39 Million - $2.73 Million	14,274	14,274 $2.66 Million

Others Institutions Holding AMGN

# of Institutions

3,122

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $155B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Connable Office Inc, based on Form 13F filings with the SEC.

News

Stay updated on Connable Office Inc with notifications on news.

Account

Connable Office Inc Amgen Inc Transaction History